Valuation
Is the price right?2/2 inputs reported · High confidence
Stronger than most peers on:
- ▲ P/B
- ▲ Earnings yield
Behind the score
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Nov 1, 2026
2/2 inputs reported · High confidence
Stronger than most peers on:
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
1/1 inputs reported · High confidence
Close to the peer norm on every measure.
Earnings-per-share growth versus other banks and insurers.
2/2 inputs reported · High confidence
Weaker than most peers on:
Return on equity and return on assets versus other banks and insurers.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
No major changes
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Revenue (12 months) | 10.9B GBP | 11.1B GBP | +1.7% |
| Net income (12 months) | 7.0B GBP | 7.2B GBP | +2.2% |
| Cash | 252.8B GBP | 256.5B GBP | +1.4% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Operating margin | 231.5% | — | — | — | — | — |
| Net margin | 71.8% | 62.4% | 52.7% | 58.9% | 64.6% | ▲ 5.7 pts |
| Return on assets (ROA) | 0.5% | 0.4% | 0.4% | 0.4% | 0.5% | ▲ 0.0 pts |
| Return on equity (ROE) | 10.2% | 8.7% | 7.4% | 8.8% | 9.2% | ▲ 0.4 pts |
| Interest coverage | 7.13× | — | — | — | — | — |
Price history is added with the daily price update and will appear after the next one.